Monthly Archives: December 2017

Top 3 Tips on App Development Revealed By Mobile App Agency

App Developers looking for the latest info on how to overcome issues with Android App Development can stop by Glance Creative Ltd for a rundown of the top 3 tips on the subject.

London, United Kingdom – December 28, 2017 /PressCable/ —

Glance Creative Ltd, a mobile app development agency based in London has released a free tip sheet to help App Developers cut through the clutter and get to the most important aspects of Android App Development and overcoming the issues that are essential for success. The full list of tips can be found on the company’s website, https://thisisglance.com/android-app-development/.

Some of the most effective tips include:

How to overcome issues with Android App Development – this includes information on how to solve the most common issues when starting on an app development idea such as targeting the audience effectively, how to overcome functionality issues on certain devices and more.

Marketing the app to a target audience – useful tips on how to focus on user behaviour, psychology and engagement to ensure the app is built correctly right from the start.

How to learn the usage figures of each device type – Many apps are unable to function properly on a specific device family and therefore solutions have to be made.

When asked about the reasons behind the tip sheet, Simon Lee, CEO of Glance Creative Ltd said,

“Unlike other Android app development companies, we understand how overcoming these common issues is essential throughout the entire product process and not just at the end. This is why we build our apps with the end goal in mind, the end-user and the marketing to reach them. The aim of this tipsheet is to allow developers to spend less time convincing people to actually use their app and instead shift the focus to making people aware that it exists; the app will then do the rest.”

The tip sheet is available for free and App Developers are encouraged to share the tips with others who find the information useful. Any questions can be answered by going to the company website, http://thisisglance.com/ and filling out the contact form there.

Business contact information can be found below:

Glance Creative Ltd

Unit 302, Cannon Wharf Business Centre, Pell Street,London,SE8 5EN

0203 811 0484

Contact Info:
Name: Simon Lee
Email: Send Email
Organization: Glance Creative Ltd
Address: Unit 302, Cannon Wharf Business Centre , London SE8 5EN, United Kingdom

For more information, please visit http://thisisglance.com/

Source: PressCable

Release ID: 278538

Happy New Years announced by Kayser after incredible year of exponential growth

Kayser the number one intimates, sleepwear, socks designer and manufacturer seeks global distributors. Thinking outside the box: Ross is quoted as saying: “Once you become fearless, you become limitless.” The Kayser Global Initiative is to have franchised stores in every capital city.

Los Angeles, United States – December 28, 2017 /PressCable/ —

Kayser and Ross wish you an outstanding New Years filled with success, health, happiness and fearlessness!

Kayser, the renowned 100 year old brand, designer and manufacturer of intimate underwear, sleepwear and socks for family men, women and children, has launched a search for global entrepreneurs. In addition to this, it has welcomed Créations Cindy Ann, Inc. as exclusive Canadian Franchisee Distributor.

It’s been a great year states Ross of Kayser International. Kayser signed distribution deals in the USA, Canada, The Middle east and South America. Ross is looking forward to open the territories in Jamaica, The Bahamas, Trinidad and Tobago, Grenada, France, Pakistan, Bangladesh and many other countries around the world.

Ross, a native of New York City, has been involved with the apparel and celebrity licensing arena for 35 years. Ross was a professional recording artist in France at 17 years old. He then transitioned to acting in TV, commercials, film, and theater. After touring as Berger in HAiR the Musical, Ross created “She’s Got Legs” cotton lycra printed hip hugger bell-bottoms in the early 80’s. The bell-bottoms became a hit in the modeling and rock star world. Brooke Shields often visited the Broadway and Spring Street location. The brand was carried by Macy’s and his own retail outlet in Soho, NYC. In response to a question on the driving force behind his success, Ross has explained how it really boiled down to finding his passion in making a difference for others on a global scale. He consults with entrepreneurs to design programs within their business niche to give back to their workers, families and communities.

Founded in 1908 in the United States, Kayser is the top provider of family intimate sleepwear in Chile. It has 352 branches in 44 countries around the world, with over two thousand ports of sale, and is now in the Middle East, South America, Mexico, the Caribbean, Canada and the USA.

For franchisees, owners and investors, an exclusive agent is required in many countries. Kayser provides the franchisee and distributor with everything they need, including marketing, store fixtures, apparel and Amazon personal contact.

The opportunity is managed by Sherwin “Ace” Ross, a recognized New York / Los Angeles apparel and marketing executive, former president of ONE Clothing Company. Today, Ace represents Kayser, the number one sleepwear company in Chile, with 70 stores, and wholesale and retail distribution in 44 countries.

The Kayser Global Initiative: Kayser will have a store in every capital city including online and wholesale distribution in every country! The company is now seeking franchising and distributor partners in numerous European, African, Far East countries, The Bahamas, Trinidad, Tobago, The Bahamas and Cuba so that the brand can be expanded creating jobs and enterprise on a Global scale.

Now Ace is determined to help Kayser reach the next level as the international representative of the company. Ace said that the key to his success is being passionate about what to choose to do, so it does not become a job or work.

For more information on becoming an exclusive Kayser Franchise Distributor, interested parties can reach out to: Sherwin Ace Ross, Kayser International, Ace Ross Studios, Phone: +1-213-884-8448

Contact Info:
Name: Sherwin “Ace” Ross
Email: Send Email
Organization: Kayser Intimates / Sleepwear / Hoisery
Address: 110 E 9th Street, Los Angeles, CA 90079, United States
Phone: +1-213-884-8448

For more information, please visit http://www.aceross.com

Source: PressCable

Release ID: 280911

Round Rock TX Flood Repair Water Damage Restoration & Removal Services Launched

Seeking to help more people restore their home or business after water damage, fire or a natural disaster, Round Rock Reconstruction Service Pros have expanded their services to include water damage restoration. Round Rock Reconstruction Service Pros quickly restores dwellings to their original state.

Round Rock, United States – December 28, 2017 /PressCable/ —

Seeking to help more people restore their home or business after water damage, fire or a natural disaster, Round Rock Reconstruction Service Pros have expanded their services. Now servicing most of Texas, Round Rock Reconstruction Service Pros responds quickly to restore dwellings to their original state.

The popular water damage restoration experts Reconstruction Service Pros, available at 512-318-2599, announced it is now offering its coveted range of water removal and property clean-up, sanitizing or repair and rebuilding services for clients in Round Rock, Texas.

As part of its campaign to reach a wide range of North American regions, Reconstruction Service Pros has available to clients in Round Rock, Texas, and the surrounding area.

More information is available athttps://goo.gl/maps/jKokjsPt3bA2 .

Reconstruction Service Pros is an acclaimed water damage restoration company with decades of experience helping people across the country quickly restore their homes or business properties back to original condition after storms, floods, broken pipes and any other plumbing or water emergencies.

The company has announced it is now offering its complete range of water damage restoration services for clients in Round Rock, Texas, who want to properly contain a water emergency and quickly restore a normal living or work environment for their family and staff.

As a full-service flood remediation contractor, the company offers its clients the quick water and moisture removal needed to avoid any secondary damage to the property and salvage flooring, furniture, carpets or other belongings and the professional cleaning, drying, disinfection and sanitizing required to eliminate any toxins and inhibit the spread of mold & mildew.

Once the emergency is contained, the origin of the damage fixed and the area properly dry, disinfected and sanitized, the restoration company will also help with any necessary repairs, renovations and rebuilding tasks the client may need, including new walls, floors or ceilings.

All these clean-up and restoration services are delivered by seasoned professionals who are on call 24/7 and at the client’s residence in an hour to contain or fix the water problems with a friendly, knowledgeable service that can ensure some peace of mind in times of need.

The Reconstruction Service Pros team explains that “it only takes a broken pipe or a sudden storm to cause major water damage to a home or business. When that happens, all the owners have to do is call us the Water Damage Restoration Professionals. They’ll be there within the hour to contain the problem and help return the property back to normal.”

Estimates and consultations with Reconstruction Service Pros and more information on the complete range of 24/7 water damage restoration services it can now offer in Round Rock, Texas are available at 512-318-2599 or through the website link provided Round Rock Reconstruction Services Pros.

Contact Info:
Name: Kelly Reich
Organization: Round Rock Reconstruction Service Pros
Address: 402 West Palm Valley Boulevard, Round Rock, TX 78664, United States
Phone: +1-512-897-7488

For more information, please visit http://roundrock.reconstructionservicepros.com

Source: PressCable

Release ID: 282021

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of INC Research Holdings, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 30, 2018 – INCR

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of INC Research Holdings, Inc. (“INCR”) (NASDAQ: INCR) between May 10, 2017 and November 9, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of New York. To get more information, go to:

http://www.zlk.com/plsra-c/inc-research-holdings-inc?wire=2

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that, throughout the Class Period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the merger with inVentiv Health, Inc. (“inVentiv”) was not providing the benefit that defendants stated it would; (2) inVentiv was underperforming; (3) in turn, INCR’s 2017 financial performance would be negatively impacted; and (4) as a result, defendants’ statements about INCR’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

If you suffered a loss in INCR, you have until January 30, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll-Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 485084

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of RYB Education, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 26, 2018 – RYB

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired American Depositary Shares of RYB Education, Inc. (“RYB”) (NYSE: RYB) pursuant to the September 27, 2017 IPO or between September 27, 2017 and November 22, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of New York. To get more information, go to:

http://www.zlk.com/plsra-c/ryb-education-inc?wire=2

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that, throughout the Class Period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) RYB failed to establish safety policies to prevent sexual abuse from occurring at its schools; (ii) RYB’s failure to remedy problems within its system exposed children to harm and unreasonable risk of harm while in the Company’s care; and (iii) as a result of the foregoing, RYB securities traded at artificially inflated prices during the Class Period, and class members suffered significant losses and damages.

On November 24, 2017, media outlets announced that parents had accused an RYB nursery of drugging and abusing children. Then on November 27, 2017, RYB announced that one “teacher at the RYB-operated kindergarten in question was detained as a criminal suspect for maltreatment of children in the facility…”

If you suffered a loss in RYB, you have until January 26, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll-Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 485083

ALKS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Alkermes plc and a Lead Plaintiff Deadline of January 22, 2018

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Alkermes plc (“Alkermes”) (NASDAQ: ALKS) securities between February 24, 2015 and November 3, 2017.

Click here to learn about the case: http://www.wongesq.com/pslra-sb/alkermes-plc?wire=2. There is no cost or obligation to you.

According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (i) Alkermes had engaged in deceptive marketing campaigns to influence policymakers to use Vivitrol in addiction treatment programs over more scientifically proven and efficacious alternatives; (ii) the foregoing conduct, when disclosed, would subject Alkermes to heightened regulatory and legislative scrutiny; (iii) accordingly, the Company’s revenues derived from Vivitrol during the Class Period were unsustainable; and (iv) as a result of the foregoing, Alkermes shares traded at artificially inflated prices during the Class Period, and class members suffered significant losses and damages.

If you suffered a loss in Alkermes, you have until January 22, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sb/alkermes-plc?wire=2.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 485082

ACOR INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Acorda Therapeutics, Inc. and a Lead Plaintiff Deadline of January 17, 2018

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Acorda Therapeutics, Inc. (“Acorda”) (NASDAQ: ACOR) securities between April 18, 2016 and November 14, 2017.

Click here to learn about the case: http://www.wongesq.com/pslra-sb/acorda-therapeutics-inc?wire=3. There is no cost or obligation to you.

According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (i) the drug treatment, tozadenant, entailed significant undisclosed safety risks; (ii) accordingly, the Company had overstated tozadenant’s approval prospects and commercial viability; (iii) the Company had likewise overstated the benefits of the Biotie Acquisition; and (iv) as a result of the foregoing, Acorda’s shares traded at artificially inflated prices during the Class Period.

On November 15, 2017, Acorda revealed it had ceased enrolling new patients in its Phase 3 trial of its Parkinson’s treatment due to patient deaths.

If you suffered a loss in Acorda, you have until January 17, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sb/acorda-therapeutics-inc?wire=3.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 485081

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Meridian Bioscience, Inc. and Set a Lead Plaintiff Deadline of January 16, 2018 — VIVO

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired shares of Meridian Bioscience, Inc. (NASDAQ: VIVO) between March 25, 2016 and July 13, 2017. You are hereby notified that Levi & Korsinsky has commenced the class action Forman v. Meridian Bioscience, et al. (Case No. 1:17-cv-00774-SJD) in the USDC for the Southern District of Ohio. Click here to view the complaint. To get more information, go to:

http://www.zlk.com/pslra-sbm/meridian-bioscience-inc-2?wire=2

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that its subsidiary, Magellan Diagnostics, Inc., manufactured lead testing systems that provide inaccurate results.

On March 24, 2016, Meridian completed its acquisition of Magellan Biosciences, Inc. and its subsidiary, Magellan Diagnostics, Inc. On May 17, 2017, the U.S. Food and Drug Administration and Centers for Disease Control and Prevention issued a press release “warning Americans that certain lead tests manufactured by Magellan Diagnostics may provide inaccurate results” Then, on July 13, 2017, the FDA issued a statement that as part of an “aggressive investigation” the FDA had inspected Magellan Diagnostics’ facility and issued a report including “several inspectional observations that may be violations of federal law.”

If you suffered a loss in Meridian Bioscience, you have until January 16, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY10004
Tel: (212) 363-7500
Toll-Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 485080

The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Omega Healthcare Investors, Inc. Shareholders and a Lead Plaintiff Deadline of January 16, 2018

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Omega Healthcare Investors, Inc. (NYSE: OHI) who purchased shares between February 8, 2017 and October 31, 2017. The action, which was filed in the United States District Court for the Southern District of New York, alleges that the Company violated federal securities laws.

In particular, the complaint alleges that, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) financial and operating results of certain of the Company’s operators were deteriorating; (2) as a result, certain of the Company’s operators were experiencing worsening liquidity issues that were significantly impacting the operators’ ability to make timely rent payments; (3) as a result, certain of the Company’s direct financing leases were impaired and certain receivables were uncollectible; and (4) that, as a result of the foregoing, Defendants’ statements about Omega’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

Shareholders have until January 16, 2018 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.

If you suffered a loss during the Class Period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sb/omega-healthcare-investors-inc?wire=2.

Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 485079

NOVN INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Novan, Inc. and a Lead Plaintiff Deadline of January 2, 2018

NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Middle District of North Carolina on behalf of investors who purchased Novan, Inc. (“Novan”) (NASDAQ: NOVN) securities (1) pursuant and/or traceable to Novan’s IPO on or about September 26, 2016 or (2) between September 26, 2016 and August 1, 2017.

Click here to learn about the case: http://www.wongesq.com/pslra-sbm/novan-inc?wire=3. There is no cost or obligation to you.

The complaint alleges that the Company made materially false and/or misleading statements in its Registration Statement and Prospectus for the IPO, and made false statements throughout the class period. In particular, among other allegations, the complaint alleges that the Company repeatedly falsely stated that two Phase 3 clinical trials for the treatment SB204 were identical and omitted specific facts as to why the two critical trials were, in fact, not identical; as a result of these false statements, the Company’s outlook and expected financial performance were not accurately represented.

If you suffered a loss in Novan, you have until January 2, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sbm/novan-inc?wire=3.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 485078